Cannabinoid Hyperemesis Syndrome Treated With Fosaprepitant: A Case Report
Abstract Cannabinoid hyperemesis syndrome (CHS) is a condition in which users of marijuana experience symptoms of nausea and vomiting. Due…
aprepitant
Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting
Abstract The management of chemotherapy-induced nausea and vomiting (CINV) in children remains challenging due to differences in the chemotherapy regimens,…
Underlying factors related to HIV/AIDS prevention: investigating the willingness to take pre-exposure prophylaxis among men-who-have-sex-with-men in Germany
Abstract Background: This study investigates the willingness of men-who-have-sex-with-men (MSM) to use HIV pre-exposure prophylaxis (PrEP). Research in the HIV/AIDS…
Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
Abstract Cannabis hyperemesis syndrome (CHS) is a clinical syndrome associated with prolonged and regular cannabis use. CHS is characterized by…
Chemotherapy- and cancer-related nausea and vomiting
Abstract Approximately one half of cancer patients will experience nausea or vomiting during the course of their disease either because…